Sheba Medical Center, Tel Hashomer
Ruty Mehrian-Shai is the Head of the Brain Cancer Molecular Medicine at Sheba Medical Center, Tel Hashomer. Prior to this role, they served as a Scientific Executive at the Diagnostic Laboratory of Hy Lab and Patholab and as an Assistant Professor of Research Biochemistry and Molecular Biology at the Keck School of Medicine of the University of Southern California. Ruty holds a PhD in Brain Cancer from the University of Southern California and a PhD in Immunology from The Hebrew University of Jerusalem. They also have postgraduate degrees in Brain Cancer Genetics from UCLA and Intercampus Medical Genetics from Cedars Sinai. Additionally, they hold a degree in Medical Genetics from UCLA and another PhD in Immunology from The Hebrew University of Jerusalem.
Sheba Medical Center, Tel Hashomer
Established in 1948, Sheba Medical Center, Israel’s City of Health, is the largest, most comprehensive healthcare facility in the Middle East and one of the best hospitals in the world according to Newsweek Magazine. As a global healthcare leader, Sheba is committed to providing patients everywhere hope without boundaries by sharing its knowledge and experience with healthcare professionals, governments, and medical institutions. With this in mind, Sheba Global was created to serve as the medical center’s global ambassador and help elevate healthcare standards worldwide through education and training programs, consulting services, humanitarian aid, as well as the provision of medical care to international patients.